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Abstract Alterations in hemoglobin oxygen affinity can be
detected by exposing blood to different PO2 and recording
oxygen saturation, a method termed tonometry. It is the gold
standard to measure the PO2 associated with 50 % oxygen
saturation, the index used to quantify oxygen affinity
(P50Tono). P50Tono is used in the evaluation of patients
with erythrocytosis suspected to have hemoglobin with ab-
normal oxygen affinity. Since tonometry is labor intensive
and not generally available, we investigated whether accu-
rate estimates of P50 could also be obtained by venous blood
gas analysis, co-oximetry, and standard equations (P50Ven).
In 50 patients referred for evaluation of erythrocytosis, pH,
PO2, and oxygen saturation were measured in venous blood
to estimate P50Ven; P50Tono was measured for comparison.
Agreement among P50Ven and P50Tono was evaluated
(Bland–Altman analysis). Mean P50Tono was 25.8 (range
17.4–34.1) mmHg. The mean difference (bias) of P50Tono-
P50Ven was 0.5 mmHg; limits of agreement (95 % confi-
dence limits) were −5.2 to +6.1 mmHg. The sensitivity and
specificity of P50Ven to identify the 25 patients with
P50Tono outside the normal range of 22.9–26.8 mmHg were
5 and 77 %, respectively. We conclude that estimates of P50
based on venous blood gas analysis and standard equations
have a low bias compared to tonometry. However, the
precision of P50Ven is not sufficiently high to replace
P50Tono in the evaluation of individual patients with sus-
pected disturbances of hemoglobin oxygen affinity.
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Introduction
The causes of erythrocytosis, i.e., an increased erythro-
cyte mass, include either a decreased plasma volume
(relative erythrocytosis) or an increase in the erythrocyte
mass (absolute erythrocytosis) as determined by radio-
nucleotide techniques. Absolute erythrocytosis may be
primary due to myeloproliferative neoplasia (polycythe-
mia vera), congenital due to erythropoietin receptor muta-
tions, or secondary due to various causes including
cardiopulmonary or renal disease, congenital due to
defects of the oxygen sensing pathway (VHL, PHD2,
or HIF-2α gene mutations) or other rare congenital
defects like hemoglobin variants or bisphosphoglycerate
mutase deficiency (Table 1). Guideline for the investiga-
tion of erythrocytosis [1, 2] suggest to search for poly-
cythemia vera and other common causes by history
including the use of medication, clinical examination, full
blood count, renal and liver function tests, serum ferritin,
vitamin B12, and erythropoietin measurement, arterial
blood gas analysis, chest radiography, and abdominal
ultrasonography. If the etiology of the erythrocytosis
remains unclear, a more specialized stage 2 evaluation
includes whole body CT scan, bone marrow examination,
cytogenetics of the bone marrow aspirate, high perfor-
mance liquid chromatography of the hemoglobin, and
determination of the oxygen-hemoglobin dissociation
curve. It allows to detect hemoglobin variants with al-
tered oxygen affinity as rare cause of erythrocytosis [3,
4]. The hemoglobin oxygen affinity is quantified during
tonometry by exposing blood to changing partial pres-
sures of oxygen (PO2) while continuously recording ox-
ygen saturation. The P50, i.e., the PO2 at which 50 % of
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the hemoglobin is saturated with oxygen, is used as the
numeric value characterizing hemoglobin oxygen affinity
(Fig. 1). Unfortunately, tonometry is time consuming and
requires expensive equipment. The technique is therefore not
widely available. Estimation of the P50 from venous blood gas
analysis and co-oximetry using standard equations according
to Severinghaus [5] has been suggested as a simpler alterna-
tive to tonometry. However, this approach of determining the
P50 has not been well validated [6, 7]. The purpose of the
current study is therefore to evaluate the accuracy of P50
estimated from venous blood gas analysis in comparison to
tonometry, the gold standard for measurement of P50, in
patients referred for evaluation of erythrocytosis.
Methods
Patients
Data from all patients referred to the Hematology and
Pulmonary Division, University Hospital of Zurich, from
2007 to 2009 for arterial and venous blood gas analysis and
tonometry as part of the diagnostic evaluation of erythrocyto-
sis, were included. The protocol was in accordance with the
Declaration of Helsinki and approved by the Institutional
Ethics Committee of the University Hospital of Zurich.
Measurements
Blood analysis
Venous and arterial blood samples were obtained from a
cubital vein and radial artery, respectively, and analyzed
immediately. Blood gas analysis and co-oximetry were per-
formed by an ABL (700 Series, Radiometer Copenhagen)
device. P50 was measured by tonometry (P50Tono) (Hemox-
Analyser, model B, TCS, Medical Products Division,
Southampton, PA). The tonometer measures hemoglobin
fractions by two-wavelength spectrophotometry and PO2
by a Clark electrode during exposure of the blood sample
to increasing O2 fractions from 0.21 to 1.0. Validation
studies and the normal range for the P50 measured with this
device (22.9-26.8 mmHg) have been published [8]. P50 was
also calculated from the oxygen saturation and PO2
Table 1 Differential diagnosis of erythrocytosis
Primary causes of erythrocytosis
Congenital: Erythropoietin receptor mutations
Acquired: Polycythemia vera
Secondary causes of erythrocytosis
Congenital: Defects of the
oxygen sensing
pathway:
VHL gene mutations
PHD2 mutations
HIF-2α mutations
Other congenital
defects:
High oxygen affinity
hemoglobin
Bisphosphoglycerate mutase
deficiency
Acquired: Central hypoxia: Smoker’s erythrocytosis
Chronic lung disease
Hypoventilation syndromes
including obstructive sleep
apnea
Right-to-left cardiopulmonary
vascular shunts
High altitude
Carbon monoxide poisoning
Local hypoxia: Renal artery stenosis
Hydronephrosis
Renal cysts (polycystic kidney
disease)
Post-renal transplant
erythrocytosis
End-stage renal disease
Pathologic EPO
production
Cerebellar hemangioblastoma
Meningioma
Parathyroid carcinoma/adenoma
Hepatocellular carcinoma
Renal cell cancer
Pheochromocytoma
Uterine leiomyoma
Drug associated Erythropoietin administration
Androgen administration
Idiopathic erythrocytosis
Fig. 1 Standard oxygen dissociation curve according to the Severin-
ghaus equation. The arterial PO2 (10.9 kPa), the venous PO2 (3.8 kPa),
and the P50 measured by tonometry (2.3 kPa) in a patient with eryth-
rocytosis due to a high-affinity hemoglobin variant (heterozygous
mutation for hemoglobin Cutlerville) are indicated. The P50 estimated
from venous blood gas analysis and co-oximetry (2.8 kPa) has been
calculated by linear extrapolation of the venous PO2 to a saturation of
50 %. The values of P50 are situated to the left of the standard curve
indicating an increased oxygen affinity. kPa can be converted to mmHg
by multiplication by 7.5
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measured in the venous blood sample incorporating pH
adjustments according to Severinghaus (P50Ven). [5]:
P50 ¼ 26:7 PO2 obsð Þ PO2 stdð Þ= ð1Þ
Where
PO2 obsð Þ; pH 7:4 ¼ PO2  e1:1 pH7:4ð Þ ð2Þ
And
PO2 stdð Þ : exp 0:385 ln S1  1
 1 þ 3:32 72Sð Þ1  S6 6=
 
ð3Þ
The normal range for the P50 calculated with this formula
is 25.3–30.7 mmHg [9].
Clinical diagnosis
A detailed medical history, clinical examination, and labo-
ratory tests were obtained in all patients according to pub-
lished guidelines for evaluation of erythrocytosis. [1, 2]
Data analysis and statistics
Data are summarized by counts, means, and SD. The accu-
racy of the P50 calculated from the venous blood using the
Severinghaus equation was compared to corresponding val-
ues measured by tonometry by a Bland–Altman analysis
[10]. Diagnostic accuracy of P50Ven was also determined
in terms of sensitivity and specificity to detect an abnormal
P50Tono.
Results
Data from 50 patients (13 women) with mean age 46.1 years,
SD 15.5, and a range from 20 to 76 years were available.
Their clinical diagnoses along with the number of patients
with a P50Tono outside the normal range of 22.9 to
26.8 mmHg are listed in Table 2. In 14 patients, the cause
of erythrocytosis could not be definitively determined de-
spite extensive evaluations. Tonometry revealed a mean
P50Tono of 25.8 mmHg (range 17.4 to 34.1 mmHg) with
25 of the 50 values outside the normal range. Only seven of
the 25 abnormal results were below the lower limit of
22.9 mmHg, in one of these patients abnormal hemoglobin
with high oxygen affinity could be identified (Hemoglobin
Cutlerville). The majority of patients with myeloprolifera-
tive disorder showed an elevated P50Tono (>26.8 mmHg),
probably due to secondary regulatory mechanisms.
The corresponding P50Ven was 26.3 mmHg (range 20.9
to 29.4 mmHg). Figure 2 shows the Bland–Altman analysis
evaluating the accuracy of P50Ven compared to P50Tono.
The bias was +0.5 mmHg with limits of agreement (95 %
confidence interval) from −5.2 to +6.1 mmHg. Table 3
shows the diagnostic performance of the P50Ven compared
to P50Tono. The sensitivity was 5 %, the specificity was
77 %, and the positive and the negative predictive values
were 12 and 57 %, respectively.
Discussion
The current study is the largest comparison of P50 estimated
by blood gas analysis and co-oximetry of venous blood
Table 2 Diagnoses of patients with normal and abnormal P50 by tonometry
P50 by tonometry, mmHg Suspected etiology of abnormal P50
Diagnosis No.
patients
Low
<22.9
Normal range
22.9–26.8
High
>26.8
Myeloproliferative neoplasia 15 2 6 7 JAK-2 mutation was positive in 7, negative
in 2, and not analyzed in 6 patients
Smokers erythrocytosis 11 0 8 3 Elevated COHb >3 %
Relative erythrocytosis 9 1 6 2 Gaisböck syndrome
High-affinity hemoglobin 1 1 0 0 Hemoglobin Cutlerville
Post-renal transplant
erythrocytosis
1 0 0 1 Erythropoietin elevation
Cardiovascular disease 1 0 0 1 Congenital pulmonary stenosis
Pulmonary disease 1 0 1 0 COPD
Hereditary spherocytosis 1 0 1 0 Erythrocyte membrane disorder
Idiopathic/unclear 14 3 6 5 etiology not identified
Totala 54 7 28 19
a The total number exceeds 50 because four smokers had a combined etiology of erythrocytosis (one patient had chronic obstructive pulmonary
disease (COPD), one had a myeloproliferative neoplasia, and two had Gaisböck syndrome)
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using standard equations with tonometry, the gold standard
for P50, in patients with erythrocytosis. We found that de-
spite a negligible bias, the precision of the values of P50Ven
was not sufficiently high to allow their use as substitutes for
P50Tono in the clinical evaluation of polycythemia in indi-
vidual patients.
Unfortunately, determination of P50 by tonometry is not
feasible in many institutions because it is labor intensive,
time consuming, and requires specialized equipment.
Replacement of this technique by a simpler method based
on venous blood gas analysis would therefore be desirable.
However, P50Ven has not been well established as a means
to assess hemoglobin oxygen affinity, possibly due to the
lack of appropriate validation. We identified only two studies
involving less than 30 patients in whom P50Ven was evaluated
in comparison to tonometry. The first one has been published
by Kohzuki et al. [7]. In this study, the P50Ven of 25 normal
Japanese adults has been compared to the P50 obtained by
microtonometry. With this technique, 6 discrete points on the
dissociation curve at different PO2 were determined by a
tonometer instead of the complete dissociation curve recorded
in the current study. The mean ±SD deviation of the P50
derived from venous blood and the 6-point technique in the
cited study was 0.4±2.5 Torr (at pH 7.4, PCO2 40 Torr and
37 °C); similar results were obtained for pH 7.2 and 7.6. In the
second study by Aberman et al. [6], the P50Ven at various SO2
(between 20 and 90%) were determined in 135 blood samples
from 21 healthy nonsmokers and in eight patients. The stan-
dard deviation of P50Ven on the same sample of blood at
different SO2 was ±1.0 Torr. A validation of the P50Ven
comparison to P50Tono has not been performed in this study.
Based on their results, the authors of both studies suggested
that P50Ven could serve as a simple surrogate for assessment
of the hemoglobin oxygen affinity. However, our data
obtained in a larger group of 50 patients do not support these
expectations because of the imprecision of P50Ven values in
comparison to tonometry. The scatter of P50Ven resulted in a
low diagnostic accuracy in detecting patients with an abnor-
mal P50Tono with positive and negative predictive values of
only 12 and 57 %, respectively, which is inappropriate for
clinical use.
Based on our data, we are unable to differentiate whether
the imprecision of P50Ven was mainly related to instrument
variability or to physiological reasons. However, the mea-
surement techniques used for blood gas analysis and co-
oximetry are the same as for tonometry and we therefore
speculate that deviations in the shape of the individual
hemoglobin dissociation curve from the standard curve
explains some of the discrepancy between P50Ven and
P50Tono. The narrow normal range of P50 (3.9 mmHg, i.e.,
from 22.9 to 26.8 mmHg) together with the only slight
deviation of P50 that is associated with abnormal hemoglo-
bin variants (see example in Fig. 1) suggests that measure-
ment of P50 should be performed with a greater precision
than what can be expected from P50Ven. According to a
study by Guarnone et al. [8], the P50Tono measured by the
tonometer used in the current study has a small intra-assay
variability with a standard deviation of 0.39 mmHg suggest-
ing that relatively small deviations of P50 from the normal
range can be detected.
Guidelines for investigation of erythrocytosis by
McMullin et al. [1, 2] suggest that a genetic analysis of a
potential hemoglobin variant should only be performed if
other more common causes of erythrocytosis have been
evaluated. Our study indicates that determination of P50 by
tonometry but not P50Ven may help to further guide clinical
Fig. 2 Bland–Altman analysis of P50 estimated from a venous blood
gas analysis using the Severinghaus equation vs. corresponding values
measured by tonometry. Upper panel identity plot; lower panel differ-
ences vs. mean values. Different symbols reflect the etiology of the
erythrocytosis (myeloproliferative vs. other etiologies)
Table 3 Diagnostic performance of P50 estimated from venous blood
gas analysis
P50 calculated from venous
blood gas analysis (P50Ven)
Abnormal normal
P50 measured by
tonometry
(P50Tono)
Abnormal 1 (low) 24 (P50Tono low
in 6, high in 18)
Normal 7 (P50Ven low) 18
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investigations directed at identifying rare causes of polycy-
themia. This is also emphasized by a recent study by Rumi
et al. [11], where tonometry, besides other clinical tests,
illustrated the utility of P50 measurement in the diagnostic
process of isolated erythrocytosis in 102 patients with
erythrocytosis.
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